North America & Europe Oxygen Therapy Market Anticipated To Achieve A CAGR Of 7.60% by Emerging Trends, Share, Growth Rate, Opportunities And Market Forecast To 2028

New York, United States, Tue, 27 Oct 2020 23:39:52 / Comserve Inc. / -- The North America & Europe oxygen therapy market is anticipated to achieve a CAGR of 7.60% during 2021-2028. Respiratory diseases such as pneumonia is a dangerous disease that has taken lives of numerous people over the years.

Research Nester has released a report titled "North America & Europe Oxygen Therapy Market – Regional Demand Analysis & Opportunity Outlook 2028" which also includes some of the prominent market analyzing parameters such as industry growth drivers, restraints, supply and demand risk, market attractiveness, year-on-year (Y-O-Y) growth comparisons, market share comparisons, BPS analysis, SWOT analysis and Porter's five force model.

In comparison to other infectious diseases, pneumonia killsa large number of children, states UNICEF.

Respiratory diseases such as pneumonia is a dangerous disease that has taken lives of numerous people over the years. Increasing global concern for the risk of such diseases is raising the need amongst the nations, especially the high-income countries, such as the US and Germany, to increasingly invest on minimizing and managing the risks of such diseases effectively. Additionally, the surge in the demand for respiratory support systems, such as oxygen cylinders on the back of the growing prevalence of pneumonia and other respiratory diseases, such as Chronic Obstructive Pulmonary Disease (COPD), asthma, and others, has raised the need for oxygen therapy treatments, which in turn is anticipated to drive the growth of the market.

The North America & Europe oxygen therapy market is anticipated to achieve a CAGR of 7.60% during the forecast period, i.e. 2021-2028. The market is thriving on account of the rising awareness among the medical community regarding development of products for early treatment, the development of technologically advanced oxygen therapy devices, technological innovations, growing demand for various respiratory care medical devices across the region, backed by the increasing prevalence of the respiratory diseases, changing government initiatives to improve the availability and access to medical resources, and the increasing collaboration between the manufacturers and healthcare providers.

Download Sample of This Strategic Report @ https://www.researchnester.com/sample-request-2674

The oxygen therapy market in North America is primarily driven by the U.S. on account of the rising adoption of innovative oxygen therapy technologies that helps to improve the overall quality of lifeand is expected to grow at a CAGR of 7.95% over the forecast period. Additionally, factors such as the increasing demand for oxygen therapy from nations such as Germany, UK, France & Italy are anticipated to drive the oxygen therapy market in Europe.

The North America & Europe oxygen therapy market is segmented by productinto oxygen source equipment, oxygen delivery devices and hyperbaric oxygen therapy chamber. Among these segments, the oxygen source equipment segment, which registered the largest market share of 67.97% in the year 2018, is expected to grow at a CAGR of 7.36% over the forecast period backed by the increasing need to address the challenges associated with oxygen therapy.Oxygen concentratorsare used for the provision of long-term oxygen therapy to the patients suffering from pulmonary disorders such as chronic obstructive pulmonary disease (COPD).

However, concerns for the stringent regulatory policies that retains limited number of players and also creates hindrances for new entrants into the market are anticipated to hinder the growth of the North America & Europe oxygen therapy market.

This report also studies existing competitive scenario of some of the key players of theNorth America & Europeoxygen therapymarket, which includes profiling of Koninklijke Philips PHIA, Becton, Dickinson & Company BDX, Smiths Medical, Teleflex Incorporated TFX, GE Healthcare GE, Allied Healthcare Products AHPI, Fisher & Paykel Healthcare Limited FPH, Hersill S.L, and Devilbiss Healthcare LLC.

Curious about this latest version of report? Obtain Report Details @ https://www.researchnester.com/reports/north-america-and-europe-oxygen-therapy-market/2674

The profiling enfolds key information of the companies which comprises of business overview, products and services, key financials and recent news and developments. Conclusively, the reporttitled "North America & Europe Oxygen TherapyMarket – Regional Demand Analysis & Opportunity Outlook 2028", analyses the overallNorth America & Europeoxygen therapyindustry to help new entrants to understand the details of the market. In addition to that, this report also guides existing players looking for expansion and major investors looking for investment in the North America & Europeoxygen therapy market in the near future.

Research Nester is a one-stop service provider, leading in strategic market research and consulting with an unbiased and unparalleled approach towards helping global industrial players, conglomerates and executives to make wise decisions for their future investment and expansion by providing them qualitative market insights and strategies while avoiding future uncertainties. We believe in honesty and sheer hard work that we trust is reflected in our work ethics. Our vision is not just limited to gain the trust of our clients but also to be equally respected by our employees and being appreciated by the competitors.

For more information, please contact:

Research Nester
Email: info@researchnester.com
Tel: +1-6465869123

The post North America & Europe Oxygen Therapy Market Anticipated To Achieve A CAGR Of 7.60% by Emerging Trends, Share, Growth Rate, Opportunities And Market Forecast To 2028 appeared first on Comserveonline.